SB

Shripad Bajirao Puntambekar

Active Director Director DIN 09858490
DIN 09858490 First appointment Jan 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Shripad Bajirao Puntambekar

Data last updated:

Shripad Bajirao Puntambekar is a Director at Zen Medequip Private Limited (since 2023). The company operates in Healthcare.

DIN 09858490
Primary Designation Director
Industry Healthcare
First Appointment 12 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zen Medequip Private Limited U33119PN2023PTC217898
Director12 Jan 20232023Active

Board colleagues of Shripad Bajirao Puntambekar

Directorship timeline

Open interactive timeline →
Zen Medequip Private Limited
Premium access

Shareholding and investment profile for Shripad Bajirao Puntambekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shripad Bajirao Puntambekar

Shripad Bajirao Puntambekar currently holds 1 directorship: Zen Medequip Private Limited (Director, since 12 Jan 2023).

Shripad Bajirao Puntambekar was first appointed on 12 Jan 2023 as Director at Zen Medequip Private Limited.

The current boards of Shripad Bajirao Puntambekar's companies include Ashwini Shripad Puntambekar (Zen Medequip Private Limited), Chaitali Ganesh Joshi (Zen Medequip Private Limited), Ganesh Padmakar Joshi (Zen Medequip Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available